232 related articles for article (PubMed ID: 31527358)
1. [Cancer cell-specific functional relation between Na
Fujii T; Shimizu T; Takeshima H; Sakai H
Nihon Yakurigaku Zasshi; 2019; 154(3):103-107. PubMed ID: 31527358
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between Na
Fujii T; Shimizu T; Yamamoto S; Funayama K; Fujita K; Tabuchi Y; Ikari A; Takeshima H; Sakai H
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3792-3804. PubMed ID: 30251696
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
4. [Different Membrane Environments Generate Multiple Functions of P-type Ion Pumps].
Fujii T
Yakugaku Zasshi; 2021; 141(11):1217-1222. PubMed ID: 34719540
[TBL] [Abstract][Full Text] [Related]
5. [Novel pathophysiological functions of Na
Fujii T; Shimizu T; Sakai H
Nihon Yakurigaku Zasshi; 2023; 158(6):465-468. PubMed ID: 37914325
[TBL] [Abstract][Full Text] [Related]
6. Retinoschisin and Cardiac Glycoside Crosstalk at the Retinal Na/K-ATPase.
Schmid V; Plössl K; Schmid C; Bernklau S; Weber BHF; Friedrich U
Invest Ophthalmol Vis Sci; 2020 May; 61(5):1. PubMed ID: 32392309
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
8. Identification of an amino acid substitution in human alpha 1 Na,K-ATPase which confers differentially reduced affinity for two related cardiac glycosides.
Askew GR; Lingrel JB
J Biol Chem; 1994 Sep; 269(39):24120-6. PubMed ID: 7929066
[TBL] [Abstract][Full Text] [Related]
9. Cardiac glycoside activities link Na(+)/K(+) ATPase ion-transport to breast cancer cell migration via correlative SAR.
Magpusao AN; Omolloh G; Johnson J; Gascón J; Peczuh MW; Fenteany G
ACS Chem Biol; 2015 Feb; 10(2):561-9. PubMed ID: 25334087
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
11. From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment.
Babula P; Masarik M; Adam V; Provaznik I; Kizek R
Anticancer Agents Med Chem; 2013 Sep; 13(7):1069-87. PubMed ID: 23537048
[TBL] [Abstract][Full Text] [Related]
12. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
Hauck C; Potter T; Bartz M; Wittwer T; Wahlers T; Mehlhorn U; Scheiner-Bobis G; McDonough AA; Bloch W; Schwinger RH; Müller-Ehmsen J
Eur J Pharmacol; 2009 Nov; 622(1-3):7-14. PubMed ID: 19751721
[TBL] [Abstract][Full Text] [Related]
13. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
14. Activation of cardiac ryanodine receptors by cardiac glycosides.
Sagawa T; Sagawa K; Kelly JE; Tsushima RG; Wasserstrom JA
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H1118-26. PubMed ID: 11834511
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the Na
Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into the Interactions of Digoxin and Na
Ren Y; Wu S; Burdette JE; Cheng X; Kinghorn AD
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208576
[TBL] [Abstract][Full Text] [Related]
17. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
19. Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.
Durlacher CT; Chow K; Chen XW; He ZX; Zhang X; Yang T; Zhou SF
Clin Exp Pharmacol Physiol; 2015 May; 42(5):427-43. PubMed ID: 25739707
[TBL] [Abstract][Full Text] [Related]
20. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
